These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37704912)

  • 1. Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series.
    Terheyden P; Sunderkötter C; Söhngen FD; Golle L; Schimo S; Baron R; Maihöfner C; Binder A; Pönisch W
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2461-2471. PubMed ID: 37704912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster guideline of the German Dermatology Society (DDG).
    Gross G; Schöfer H; Wassilew S; Friese K; Timm A; Guthoff R; Pau HW; Malin JP; Wutzler P; Doerr HW
    J Clin Virol; 2003 Apr; 26(3):277-89; discussion 291-3. PubMed ID: 12637076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
    Sato T; Yamamoto T; Aoyama Y
    Case Rep Dermatol; 2021; 13(1):148-153. PubMed ID: 33790759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of varicella zoster virus (VZV)-specific cell-mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster.
    Park SY; Kim JY; Kwon JS; Jeon NY; Kim MC; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2019 Nov; 91(11):1995-2000. PubMed ID: 31286531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV
    Eriksson J; Hunger M; Bourhis F; Thorén R; Popmihajlov Z; Finelli L; Jiang Y
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):613-621. PubMed ID: 31721601
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster.
    Choi S; Moon SM; Kwon JS; Kim SH; Park SY
    J Korean Med Sci; 2023 Jan; 38(2):e7. PubMed ID: 36625171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia.
    Peng Q; Guo X; Luo Y; Wang G; Zhong L; Zhu J; Li Y; Zeng X; Feng Z
    Front Immunol; 2022; 13():887892. PubMed ID: 35720399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with Brivudine in Immunocompromised Pediatric Patients with Herpes Zoster.
    Vogel C; Wetzel L; Wutzler P; Gruhn B
    Chemotherapy; 2023; 68(4):222-227. PubMed ID: 37231819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
    Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate 3-
    Ohka S; Yamada S; Nishizawa D; Fukui Y; Arita H; Hanaoka K; Iseki M; Kato J; Ogawa S; Hiranuma A; Kasai S; Hasegawa J; Hayashida M; Fukushi S; Saijo M; Ikeda AK
    Mol Pain; 2021; 17():17448069211052171. PubMed ID: 34904858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current scenario and future applicability of antivirals against herpes zoster.
    Kim SH
    Korean J Pain; 2023 Jan; 36(1):4-10. PubMed ID: 36573010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-Zoster Meningitis and Myelitis After Herpes Zoster Dermatitis Treatment With Amenamevir: A Case Series and Literature Review.
    Tada S; Kaito Y; Watanabe A; Sugiyama Y; Nishigaichi A; Miwa T; Watanabe K; Hazama T; Takahashi D
    Cureus; 2024 Feb; 16(2):e54775. PubMed ID: 38524092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.
    Wang L; Verschuuren EAM; van Leer-Buter CC; Bakker SJL; de Joode AAE; Westra J; Bos NA
    Front Immunol; 2018; 9():1632. PubMed ID: 30079064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.
    Asada H; Nagayama K; Okazaki A; Mori Y; Okuno Y; Takao Y; Miyazaki Y; Onishi F; Okeda M; Yano S; Kumihashi H; Gomi Y; Maeda K; Ishikawa T; Iso H; Yamanishi K;
    J Dermatol Sci; 2013 Mar; 69(3):243-9. PubMed ID: 23183011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system varicella zoster vasculopathy in an immunocompromised patient.
    Guedes M; Filipe R; Costa A; Soares C; Sarmento A; Tavares M
    IDCases; 2019; 15():e00483. PubMed ID: 30701156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.